174 related articles for article (PubMed ID: 2952730)
21. Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems.
Van Lier RA; Boot JH; De Groot ER; Aarden LA
Eur J Immunol; 1987 Nov; 17(11):1599-604. PubMed ID: 2960543
[TBL] [Abstract][Full Text] [Related]
22. Apparent sensitivity of human K lymphocytes to the spatial orientation and organization of target cell-bound antibodies as measured by the efficiency of antibody-dependent cellular cytotoxicity (ADCC).
Christiaansen JE; Burnside SS; Sears DW
J Immunol; 1987 Apr; 138(7):2236-43. PubMed ID: 3549899
[TBL] [Abstract][Full Text] [Related]
23. T-cell killing of target cells induced by hybrid antibodies: comparison of two bispecific monoclonal antibodies.
Clark MR; Waldmann H
J Natl Cancer Inst; 1987 Dec; 79(6):1393-401. PubMed ID: 3121901
[TBL] [Abstract][Full Text] [Related]
24. Galactosylation of human IgG monoclonal anti-D produced by EBV-transformed B-lymphoblastoid cell lines is dependent on culture method and affects Fc receptor-mediated functional activity.
Kumpel BM; Rademacher TW; Rook GA; Williams PJ; Wilson IB
Hum Antibodies Hybridomas; 1994; 5(3-4):143-51. PubMed ID: 7756579
[TBL] [Abstract][Full Text] [Related]
25. Isolation and characterization of anti-monosialoganglioside monoclonal antibody 19-9 class-switch variants.
Steplewski Z; Spira G; Blaszczyk M; Lubeck MD; Radbruch A; Illges H; Herlyn D; Rajewsky K; Scharff M
Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8653-7. PubMed ID: 2934735
[TBL] [Abstract][Full Text] [Related]
26. Distinctive role of IgG1 and IgG3 isotypes in Fc gamma R-mediated functions.
Rozsnyay Z; Sármay G; Walker M; Maslanka K; Valasek Z; Jefferis R; Gergely J
Immunology; 1989 Apr; 66(4):491-8. PubMed ID: 2523858
[TBL] [Abstract][Full Text] [Related]
27. Biological activity in the human system of isotype variants of oligosaccharide-Y-specific murine monoclonal antibodies.
Scholz D; Lubeck M; Loibner H; McDonald-Smith J; Kimoto Y; Koprowski H; Steplewski Z
Cancer Immunol Immunother; 1991; 33(3):153-7. PubMed ID: 2044080
[TBL] [Abstract][Full Text] [Related]
28. Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: effects of recombinant interleukin 2 on human effector cell lysis of human B-cell tumors.
Biddle WC; Pancook J; Goldrosen M; Han T; Foon KA; Vaickus L
Cancer Res; 1990 May; 50(10):2991-6. PubMed ID: 2334902
[TBL] [Abstract][Full Text] [Related]
29. CD16 on human gamma delta T lymphocytes: expression, function, and specificity for mouse IgG isotypes.
Braakman E; van de Winkel JG; van Krimpen BA; Jansze M; Bolhuis RL
Cell Immunol; 1992 Aug; 143(1):97-107. PubMed ID: 1377991
[TBL] [Abstract][Full Text] [Related]
30. Unusually efficient tumor cell lysis by human effectors of antibody-dependent cellular cytotoxicity mediated by monoclonal antibodies.
Christiaansen JE; Sears DW
Cancer Res; 1984 Sep; 44(9):3712-8. PubMed ID: 6744288
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies to disialogangliosides: characterization of antibody-mediated cytotoxicity against human melanoma and neuroblastoma cells in vitro.
Kawashima I; Tada N; Fujimori T; Tai T
J Biochem; 1990 Jul; 108(1):109-15. PubMed ID: 2121721
[TBL] [Abstract][Full Text] [Related]
32. Cellular cytotoxicity mediated by isotype-switch variants of a monoclonal antibody to human neuroblastoma.
d'Uscio CH; Jungi TW; Blaser K
Br J Cancer; 1991 Sep; 64(3):445-50. PubMed ID: 1911183
[TBL] [Abstract][Full Text] [Related]
33. Analysis of the monocyte Fc receptors and antibody-mediated cellular interactions required for the induction of T cell proliferation by anti-T3 antibodies.
Clement LT; Tilden AB; Dunlap NE
J Immunol; 1985 Jul; 135(1):165-71. PubMed ID: 3923099
[TBL] [Abstract][Full Text] [Related]
34. IgG Fc engineering to modulate antibody effector functions.
Wang X; Mathieu M; Brezski RJ
Protein Cell; 2018 Jan; 9(1):63-73. PubMed ID: 28986820
[TBL] [Abstract][Full Text] [Related]
35. Mitogenicity of anti-Thy-1 monoclonal antibodies attributable to an Fc-dependent mechanism.
Kummer U; Haunschild J; Reisbach G; Delecluse HJ; Thierfelder S
Eur J Immunol; 1993 Oct; 23(10):2649-54. PubMed ID: 8104797
[TBL] [Abstract][Full Text] [Related]
36. Characterization of a series of isotype switch variants of a new CD20 monoclonal antibody.
Hooijberg E; Sein JJ; van den Berk PC; Hekman A
Hybridoma; 1996 Feb; 15(1):23-31. PubMed ID: 9064283
[TBL] [Abstract][Full Text] [Related]
37. Activation of cloned human natural killer cells via Fc gamma RIII.
Werfel T; Uciechowski P; Tetteroo PA; Kurrle R; Deicher H; Schmidt RE
J Immunol; 1989 Feb; 142(4):1102-6. PubMed ID: 2464637
[TBL] [Abstract][Full Text] [Related]
38. A monoclonal antibody against hinge-cleaved IgG restores effector function to proteolytically-inactivated IgGs in vitro and in vivo.
Brezski RJ; Kinder M; Grugan KD; Soring KL; Carton J; Greenplate AR; Petley T; Capaldi D; Brosnan K; Emmell E; Watson S; Jordan RE
MAbs; 2014; 6(5):1265-73. PubMed ID: 25517311
[TBL] [Abstract][Full Text] [Related]
39. Two distinct mechanisms of antitumor activity mediated by the combination of interleukin 2 and monoclonal antibodies.
Vuist WM; van Buitenen F; Hekman A; Melief CJ
Cancer Res; 1990 Sep; 50(18):5767-72. PubMed ID: 1697500
[TBL] [Abstract][Full Text] [Related]
40. Murine monoclonal IgG3 antibodies to human colorectal tumor-associated antigens: production and characterization of antibodies active in both antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
Woodhouse CS; Morgan AC
Cancer Res; 1989 May; 49(10):2766-72. PubMed ID: 2713860
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]